Welcome to our dedicated page for Crexendo SEC filings (Ticker: CXDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Crexendo, Inc. filings document the formal disclosure record for its cloud communications and UCaaS software business. Recent Form 8-K reports include financial results furnished with service, software solutions and product revenue categories, operating expense metrics, net income, EBITDA and adjusted EBITDA measures.
The filing record also covers material corporate events and governance matters, including the completed acquisition of Estech Systems, LLC, a credit agreement with revolving and term-loan facilities, annual meeting voting results, director elections, advisory compensation votes, and Regulation FD investor-presentation disclosures. These filings describe Crexendo's financing arrangements, capital actions, shareholder approvals, governance structure and operating performance as a public software technology company.
Crexendo, Inc. director and 10% owner Steven G. Mihaylo reported open-market sales of a total of 64,994 shares of common stock, executed indirectly via a trust. The sales took place between March 6 and March 10, 2026 at prices ranging from $6.79 to $7.06 per share. Following these transactions, the trust’s indirect holdings stood at 11,241,771 shares of Crexendo common stock.
Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported open-market sales of company stock. On March 9, 2026, he sold 18,606 shares of Common Stock at an average price of $7.00 per share and a further 1,876 shares at $7.01 per share.
After these transactions, Wang directly holds 629,949 shares of Crexendo common stock. The filing reflects net sales of 20,482 shares and shows no related option exercises or derivative positions in this report.
Crexendo, Inc. Chief Strategy Officer Anand Buch reported a mix of equity compensation activity and stock sales. On March 4–5, 2026, he exercised a total of 6,251 Restricted Stock Units into common shares, with 2,555 shares withheld by the company to cover payroll taxes; the footnotes clarify these tax-withholding dispositions are not sales. He also received a grant of 10,000 ISO stock options at an exercise price of $6.47 per share, vesting monthly through 2036. On March 10, 2026, Buch made open-market sales of 34,315 shares of common stock at prices of about $6.88 and $7.01 per share. After these transactions, he directly holds 535,498 shares of Crexendo common stock.
Crexendo, Inc. director Todd Andrew Goergen reported stock-based transactions. On March 4, 2026 he received a grant of 10,000 stock options with an exercise price of $6.47 per share, expiring March 4, 2036; a footnote states these stock options vest over 36 equal monthly installments beginning April 4, 2026.
The filing also describes a prior net exercise on September 12, 2025 of options for 10,000 shares at $2.25 per share, in which he received 6,676 shares of common stock while 3,324 shares were withheld to pay the exercise price using a $6.77 stock price; the company notes this did not involve an open-market sale. After these transactions he directly holds 235,352 shares of common stock.
Crexendo, Inc. director David Roy Williams reported receiving a grant of stock options. The award covers 10,000 stock options with an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the director earns the right to exercise a portion of the options each month over three years. Following this grant, Williams is shown as holding 10,000 stock options directly.
Crexendo, Inc. director Anil K. Puri reported receiving a grant of stock options for 10,000 shares at an exercise price of $6.47 per share. This is an acquisition of derivative securities rather than an open-market stock purchase.
The options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years, aligning Puri’s potential equity ownership with longer-term service to the company.
Crexendo, Inc. director Kevin Arnold Jackson reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, giving him the right to buy company stock at that price in the future.
According to the filing, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years rather than all at once. After this grant, he holds 10,000 stock options directly.
Crexendo, Inc. director Chris McKee reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, all held as direct ownership. The options vest over 36 equal monthly installments beginning on April 4, 2026, meaning the right to exercise builds gradually over three years rather than all at once.